YOU MATTER.
Upcoming Events
Charlotte Kidney Cancer Support Group – Holiday Luncheon
November 26 @ 1:00 pm - 3:30 pm
Publications
0
%
5-Year Survival Rate Percentage increase from 2007 through 2013
0
Estimated new cases in the US, this year
0
Estimated Deaths in the US, this year
0
People are living with kidney and renal pelvis cancer, according to NCI SEER data from 2014
Evaluate your treatment options and make decisions
From the Pressroom
News from Kidney Cancer Association This feed has been created by Kidney Cancer Association
-
Trials Presented at ESMO 2018
on November 14, 2018 at 4:31 pm
In patients with previously untreated advanced renal cell carcinoma (RCC) whose tumors were positive for the PD-L1 checkpoint, a combination of the checkpoint inhibitor avelumab and the tyrosine kinase inhibitor (TKI) axitinib increased the median PFS from 8.4 months to 13.8 months when compared […]
-
Phase 1 study of everolimus and low-dose oral...
on November 14, 2018 at 4:24 pm
mTOR inhibitors are frequently used in the treatment of metastatic renal cell cancer (mRCC). mTOR regulates cell growth, proliferation, angiogenesis, and survival, and additionally plays an important role in immune regulation. Since mTOR inhibitors were shown to benefit immunosuppressive regulatory […]
-
CIP2A Promotes Proliferation, Invasion and...
on November 14, 2018 at 4:21 pm
CIP2A is a well-known oncoprotein whose expression is elevated in multiple human solid tumor types. However, its role in renal cell carcinoma (RCC) development is poorly understood.11/14/2018 […]
YOU MATTER.
WE CARE.
YOU ARE NOT ALONE.
Kidney Cancer Association
The Kidney Cancer Association (KCA) is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers.
Nobel Prize Winner: What's Next For Using Immunotherapy to Save Lives | SurvivorNet
The 2018 Nobel Prize winner for Physiology or Medicine, Dr. Jim Allison, explains immunotherapy combinations and how they can say lives.
survivornet.com
Clinical Trial Saves Life of Stage 4 Kidney Cancer Patient
When a well-known journalist in Dallas learned he had stage four kidney cancer, he was told he had three, possibly four, years to live. Now, the tumor threatening his life is gone thanks to a clinical cancer...
nbcdfw.com
8 hours ago
The latest Cancer News Daily! https://t.co/rUBExgPBGQ Thanks to @McLellanPaul @FOX_Chattanooga @YahooSports #cancer #immunotherapy
The latest Cancer News Daily! https://t.co/rUBExgPBGQ Thanks to @McLellanPaul @FOX_Chattanooga @YahooSports #cancer #immunotherapy
The latest Cancer News Daily! https://t.co/rUBExgPBGQ Thanks to @McLellanPaul @FOX_Chattanooga @YahooSports #cancer #immunotherapy
— Kidney Cancer (@KidneyCancer) November 17, 2018
20 hours ago
Dr. Jim Allison, winner of the 2018 Nobel Prize for Physiology or Medicine said future cancer research will have a large focus on combining immunotherapy with... https://t.co/QhCfPXranU
Dr. Jim Allison, winner of the 2018 Nobel Prize for Physiology or Medicine said future cancer research will have a large focus on combining immunotherapy with... https://t.co/QhCfPXranU
Dr. Jim Allison, winner of the 2018 Nobel Prize for Physiology or Medicine said future cancer research will have a large focus on combining immunotherapy with... https://t.co/QhCfPXranU
— Kidney Cancer (@KidneyCancer) November 16, 2018
20 hours ago
The latest Cancer News Daily! https://t.co/xnrStFmB8Q Thanks to @AnnaJen39609784 @Manumit1963 @OkutaOtienoDeny #cancer #smoking
The latest Cancer News Daily! https://t.co/xnrStFmB8Q Thanks to @AnnaJen39609784 @Manumit1963 @OkutaOtienoDeny #cancer #smoking
The latest Cancer News Daily! https://t.co/xnrStFmB8Q Thanks to @AnnaJen39609784 @Manumit1963 @OkutaOtienoDeny #cancer #smoking
— Kidney Cancer (@KidneyCancer) November 16, 2018